Aims Although studies have suggested good long-term results, arrhythmias, pulmonary
hypertension and left ventricular dysfunction are mentioned as sequelae long-term after …

A 5 year old girl with a haemodynamically significant mid-muscular ventricular septal defect
(VSD) had successful transcatheter closure using the Amplatzer VSD occluder. This device …

OBJECTIVES The purpose of this study was to prospectively characterize the reduction in
right atrial (RA) area and right ventricular (RV) volume after transcatheter closure of atrial …

Per-catheter devices for atrial septal defect (ASD) closure have been evolving since 1974.
The four major devices available for use on a limited basis in early 1997 are reviewed …

Conduction abnormalities and arrhythmias may occur in patients following secundum atrial
septal defect (ASD) closure using the Amplatzer® septal occluder (ASO). Therefore, the aim …

BACKGROUND: The Amplatzer Septal Occluder (ASO)(AGA Medical Corp, Golden Valley,
Minn) has gained wide acceptance for transcatheter closure of atrial septal defect (ASD). We …

The effect of operation and the effect of the imposition of an occluding device on atrial
function for patients with an atrial septal defect (ASD) has never been studied. Thus, the aim …

OBJECTIVE Large flap valve patent foramens may cause paradoxical thromboembolism
and neurological decompression illness in divers. The ability of a self expanding Nitinol wire …

OBJECTIVE To review the outcomes of transcatheter closure of atrial septal defects using
the Cardio-Seal implant. DESIGN A prospective interventional study. SETTING Tertiary …

Cardiac arrhythmias and right chamber enlargement are well known long-term sequelae of
atrial septal defect (ASD). Surgical ASD closure relieves patient symptoms but often fails to …